Share Facebook Twitter LinkedIn Pinterest Email The thirty-second in a series of regular progress reports from the High Speed Two (HS2) Independent Construction Commissioner.
MHRA approves first UK treatment for congenital thrombotic thrombocytopenic purpura (cTTP) May 12, 2025
